Literature DB >> 23150759

Mdm2 and MdmX as Regulators of Gene Expression.

Lynn Biderman1, James L Manley, Carol Prives.   

Abstract

p53 is an important tumor suppressor, functioning as a transcriptional activator and repressor. Upon receiving signals from multiple stress related pathways, p53 regulates numerous activities such as cell cycle arrest, senescence, and cell death. When p53 activities are not required, the protein is held in check by interacting with 2 key homologous regulators, Mdm2 and MdmX, and a search for inhibitors of these interactions is well underway. However, it is now recognized that Mdm2 and MdmX function beyond simple inhibition of p53, and a complete understanding of Mdm2 and MdmX functions is ever more important. Indeed, increasing evidence suggests that Mdm2 and MdmX affect p53 target gene specificity and influence the activity of other transcription factors, and Mdm2 itself may even function as a transcription co-factor through post-translational modification of chromatin. Additionally, Mdm2 affects post-transcriptional activities such as mRNA stability and translation of a variety of transcripts. Thus, Mdm2 and MdmX influence the expression of many genes through a wide variety of mechanisms, which are discussed in this review.

Entities:  

Keywords:  Hdm2; Mdm4; transcription; translation

Year:  2012        PMID: 23150759      PMCID: PMC3494367          DOI: 10.1177/1947601912455331

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  130 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Structural basis for the inhibition of caspase-3 by XIAP.

Authors:  S J Riedl; M Renatus; R Schwarzenbacher; Q Zhou; C Sun; S W Fesik; R C Liddington; G S Salvesen
Journal:  Cell       Date:  2001-03-09       Impact factor: 41.582

Review 3.  p53 family update: p73 and p63 develop their own identities.

Authors:  M S Irwin; W G Kaelin
Journal:  Cell Growth Differ       Date:  2001-07

4.  Subcellular distribution of p53 and p73 are differentially regulated by MDM2.

Authors:  J Gu; L Nie; H Kawai; Z M Yuan
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

5.  Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation.

Authors:  Gaëlle Legube; Laetitia K Linares; Claudie Lemercier; Martin Scheffner; Saadi Khochbin; Didier Trouche
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

Review 6.  Post-translational modifications and activation of p53 by genotoxic stresses.

Authors:  E Appella; C W Anderson
Journal:  Eur J Biochem       Date:  2001-05

7.  A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection.

Authors:  M Holcik; C Lefebvre; C Yeh; T Chow; R G Korneluk
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

8.  MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins.

Authors:  C H Yam; W Y Siu; T Arooz; C H Chiu; A Lau; X Q Wang; R Y Poon
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

9.  Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.

Authors:  J Parant; A Chavez-Reyes; N A Little; W Yan; V Reinke; A G Jochemsen; G Lozano
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

10.  MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.

Authors:  Lubing Gu; Harry W Findley; Muxiang Zhou
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

View more
  18 in total

1.  MDM2 controls gene expression independently of p53 in both normal and cancer cells.

Authors:  Giuseppe Arena; Romain Riscal; Laetitia K Linares; Laurent Le Cam
Journal:  Cell Death Differ       Date:  2018-07-23       Impact factor: 15.828

Review 2.  The regulation of MDM2 oncogene and its impact on human cancers.

Authors:  Yuhan Zhao; Haiyang Yu; Wenwei Hu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

3.  Rapid Optimization of Mcl-1 Inhibitors using Stapled Peptide Libraries Including Non-Natural Side Chains.

Authors:  Raheleh Rezaei Araghi; Jeremy A Ryan; Anthony Letai; Amy E Keating
Journal:  ACS Chem Biol       Date:  2016-02-19       Impact factor: 5.100

4.  Efficient mRNA polyadenylation requires a ubiquitin-like domain, a zinc knuckle, and a RING finger domain, all contained in the Mpe1 protein.

Authors:  Susan D Lee; Claire L Moore
Journal:  Mol Cell Biol       Date:  2014-08-18       Impact factor: 4.272

5.  MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.

Authors:  Alyssa M Klein; Lynn Biderman; David Tong; Bita Alaghebandan; Sakina A Plumber; Helen S Mueller; Anne van Vlimmeren; Chen Katz; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

6.  Identification of Secondary Binding Sites on Protein Surfaces for Rational Elaboration of Synthetic Protein Mimics.

Authors:  Justin M Torner; Yuwei Yang; David Rooklin; Yingkai Zhang; Paramjit S Arora
Journal:  ACS Chem Biol       Date:  2021-07-06       Impact factor: 4.634

7.  MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.

Authors:  F Mancini; L Pieroni; V Monteleone; R Lucà; L Fici; E Luca; A Urbani; S Xiong; S Soddu; R Masetti; G Lozano; A Pontecorvi; F Moretti
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

8.  Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms.

Authors:  Mary Ann Allen; Zdenek Andrysik; Veronica L Dengler; Hestia S Mellert; Anna Guarnieri; Justin A Freeman; Kelly D Sullivan; Matthew D Galbraith; Xin Luo; W Lee Kraus; Robin D Dowell; Joaquin M Espinosa
Journal:  Elife       Date:  2014-05-27       Impact factor: 8.140

9.  Expression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 area.

Authors:  Vladimir O Pustylnyak; Pavel D Lisachev; Mark B Shtark
Journal:  Neural Plast       Date:  2015-02-12       Impact factor: 3.599

10.  Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma.

Authors:  Ying Wang; Chang-Long Chen; Qiu-Zhong Pan; Ying-Yuan Wu; Jing-Jing Zhao; Shan-Shan Jiang; Jie Chao; Xiao-Fei Zhang; Hong-Xia Zhang; Zi-Qi Zhou; Yan Tang; Xu-Qiong Huang; Jian-Hua Zhang; Jian-Chuan Xia
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.